Literature DB >> 17630780

Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica.

Prakash Bhosale1, Bogdan Serban, Da You Zhao, Paul S Bernstein.   

Abstract

As in humans and monkeys, lutein [(3R,3'R,6'R)-beta,epsilon-carotene-3,3'-diol] and zeaxanthin [a mixture of (3R,3'R)-beta,beta-carotene-3,3'diol and (3R,3'S-meso)-beta,beta-carotene-3,3'-diol] are found in substantial amounts in the retina of the Japanese quail Coturnix japonica. This makes the quail retina an excellent nonprimate small animal model for studying the metabolic transformations of these important macular carotenoids that are thought to play an integral role in protection against light-induced oxidative damage such as that found in age-related macular degeneration (AMD). In this study, we first identified the array of carotenoids present in the quail retina using C30 HPLC coupled with in-line mass spectral and photodiode array detectors. In addition to dietary lutein (2.1%) and zeaxanthin (11.8%), we identified adonirubin (5.4%), 3'-oxolutein (3.8%), meso-zeaxanthin (3.0%), astaxanthin (28.2%), galloxanthin (12.2%), epsilon,epsilon-carotene (18.5%), and beta-apo-2'-carotenol (9.5%) as major ocular carotenoids. We next used deuterium-labeled lutein and zeaxanthin as dietary supplements to study the pharmacokinetics and metabolic transformations of these two ocular pigments in serum and ocular tissues. We then detected and quantitated labeled carotenoids in ocular tissue using both HPLC-coupled mass spectrometry and noninvasive resonance Raman spectroscopy. Results indicated that dietary zeaxanthin is the precursor of 3'-oxolutein, beta-apo-2'-carotenol, adonirubin, astaxanthin, galloxanthin, and epsilon,epsilon-carotene, whereas dietary lutein is the precursor for meso-zeaxanthin. Studies also revealed that the pharmacokinetic patterns of uptake, carotenoid absorption, and transport from serum into ocular tissues were similar to results observed in most human clinical studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630780      PMCID: PMC2531157          DOI: 10.1021/bi700558f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

Review 1.  Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.

Authors:  Norman I Krinsky; John T Landrum; Richard A Bone
Journal:  Annu Rev Nutr       Date:  2003-02-27       Impact factor: 11.848

2.  Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models.

Authors:  Frederick Khachik; Fabiana F de Moura; Da-You Zhao; Claude-Pierre Aebischer; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-11       Impact factor: 4.799

Review 3.  Metabolism, nutrition, and function of carotenoids.

Authors:  T W Goodwin
Journal:  Annu Rev Nutr       Date:  1986       Impact factor: 11.848

4.  Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail.

Authors:  Lauren R Thomson; Yoko Toyoda; Francois C Delori; Kevin M Garnett; Z Y Wong; Cathleen R Nichols; Kimberly M Cheng; Neal E Craft; C Kathleen Dorey
Journal:  Exp Eye Res       Date:  2002-11       Impact factor: 3.467

5.  Anhydrolutein in the zebra finch: a new, metabolically derived carotenoid in birds.

Authors:  K J McGraw; E Adkins-Regan; R S Parker
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2002-08       Impact factor: 2.231

6.  Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.

Authors:  Martha Neuringer; Marita M Sandstrom; Elizabeth J Johnson; D Max Snodderly
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

7.  The cone oil droplets of avian retinas.

Authors:  T H Goldsmith; J S Collins; S Licht
Journal:  Vision Res       Date:  1984       Impact factor: 1.886

8.  Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

Authors:  Stuart Richer; William Stiles; Laisvyde Statkute; Jose Pulido; James Frankowski; David Rudy; Kevin Pei; Michael Tsipursky; Jill Nyland
Journal:  Optometry       Date:  2004-04

9.  Lutein and zeaxanthin status and risk of age-related macular degeneration.

Authors:  Catharine R Gale; Nigel F Hall; David I W Phillips; Christopher N Martyn
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-06       Impact factor: 4.799

10.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

Authors:  Neil M Bressler; Susan B Bressler; Nathan G Congdon; Frederick L Ferris; David S Friedman; Ronald Klein; Anne S Lindblad; Roy C Milton; Johanna M Seddon
Journal:  Arch Ophthalmol       Date:  2003-11
View more
  27 in total

1.  Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.

Authors:  David I Thurnham; John M Nolan; Alan N Howard; Stephen Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-14       Impact factor: 3.117

2.  Identifying anatomical sites of carotenoid metabolism in birds.

Authors:  Kevin J McGraw
Journal:  Naturwissenschaften       Date:  2009-05-20

3.  Comment on: What is meso-zeaxanthin, and where does it come from?

Authors:  P S Bernstein; E J Johnson; M Neuringer; W Schalch; J Schierle
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

4.  Protective role of carotenoids in the visual cycle.

Authors:  Made Airanthi K Widjaja-Adhi; Srinivasagan Ramkumar; Johannes von Lintig
Journal:  FASEB J       Date:  2018-06-08       Impact factor: 5.191

5.  Inactivity of human β,β-carotene-9',10'-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment.

Authors:  Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Zhengqing Shen; Hassan Sharifzadeh; Brian M Besch; Kelly Nelson; Madeleine M Horvath; Jeanne M Frederick; Wolfgang Baehr; Paul S Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake.

Authors:  Susan T Mayne; Brenda Cartmel; Stephanie Scarmo; Haiqun Lin; David J Leffell; Erin Welch; Igor Ermakov; Prakash Bhosale; Paul S Bernstein; Werner Gellermann
Journal:  Am J Clin Nutr       Date:  2010-08-04       Impact factor: 7.045

Review 7.  What do we know about the macular pigment in AMD: the past, the present, and the future.

Authors:  Ranganathan Arunkumar; Charles M Calvo; Christopher D Conrady; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2018-03-26       Impact factor: 3.775

Review 8.  The macular carotenoids: A biochemical overview.

Authors:  Ranganathan Arunkumar; Aruna Gorusupudi; Paul S Bernstein
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-10       Impact factor: 4.698

Review 9.  What is meso-zeaxanthin, and where does it come from?

Authors:  J M Nolan; K Meagher; S Kashani; S Beatty
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

10.  Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes.

Authors:  Binxing Li; Preejith P Vachali; Zhengqing Shen; Aruna Gorusupudi; Kelly Nelson; Brian M Besch; Alexis Bartschi; Simone Longo; Ty Mattinson; Saeed Shihab; Nikolay E Polyakov; Lyubov P Suntsova; Alexander V Dushkin; Paul S Bernstein
Journal:  Exp Eye Res       Date:  2017-03-09       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.